iCell Cardiomyocytes

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

What's New

CDI launches iCell® Endothelial Cell Grant Program. Submit your proposal by Jun 8 for a chance to win. Learn More...

iCell Neurons: These human iPS cell-derived brain cells, are now available for your research needs. Learn more...

Science & Technology

CDI’s iCell Cardiomyocytes were discussed during a recent American Journal of Physiology podcast. Authors describe published research detailing the electrophysiological characterization of iCell Cardiomyocytes.

The Power of iPS Cell Technology: Any cell type. Any genetic background. Any quantity. These cells deliver. Read more...

About Us

With 100+ employees and >390 patents, CDI manufactures human iPS cell-derived cell types with the quality, quantity, and purity required for basic life science and drug discovery research. Read more...

CDI in the News

Apr 15, 2012
Genetic Engineering &
Biotechnology News
Human iPSC-Derived Cardiomyocytes

Apr 2012
Fast Company:
Top 10 Biotech

Apr 3, 2012
Wisconsin State Journal:
Madison Researchers Making Major Breakthroughs in Stem Cell Work

Mar 26, 2012
BioCentury:
iPS Predicting Toxicity

Mar 2012
Investigative Ophthalmology
& Visual Science:
Blood-derived Human iPS Cells Generate Optic Vesicle-like Structures with the Capacity to Form Retinal Laminae and Develop Synapses


WSJ Technology Innovation Awards


CDI on TwitterCDI on YouTubeCDI on LinkedIn

iCell® Products

cardiomyocytes

iCell Cardiomyocytes
Human heart cells derived from induced pluripotent stem (iPS) cells and specifically designed for drug efficacy research, toxicity screens, and more

endothelial cells

iCell Endothelial Cells
Human iPS cell-derived interior surface blood vessel cells for vascular-targeted drug discovery and predictive disease modeling

neurons

iCell Neurons
Human iPS cell-derived brain cells for drug discovery, neurotoxicity testing, and disease research

hepatocytes

iCell Hepatocytes (Coming 2012)
Human liver cells, produced from iPS cells, for disease modeling and preclinical drug development

MyCell™ Custom Services

Have a unique genotype? Ask about our custom iPS cell reprogramming and terminal cell differentiation products and services.